Viewing Study NCT00464256


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-01-03 @ 9:42 PM
Study NCT ID: NCT00464256
Status: COMPLETED
Last Update Posted: 2010-12-10
First Post: 2007-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking Cessation
Sponsor: Sanofi
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EFC5794
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Trial Transparency Team
Old Organization: sanofi-aventis

Collaborators